6MEK image
Deposition Date 2018-09-06
Release Date 2018-11-21
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6MEK
Keywords:
Title:
Crystal structure of Hepatitis C virus envelope glycoprotein E2 core in complex with human antibodies HEPC3 and HEPC46
Biological Source:
Source Organism:
Hepacivirus C (Taxon ID: 11103)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.28
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:E2 GLYCOPROTEIN
Mutagens:N448D, N576D
Chain IDs:A, C
Chain Length:235
Number of Molecules:2
Biological Source:Hepacivirus C
Polymer Type:polypeptide(L)
Molecule:HEPC3 Heavy Chain
Chain IDs:B, H
Chain Length:241
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HEPC3 Light Chain
Chain IDs:D, J (auth: L)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HEPC46 Light Chain
Chain IDs:E, G
Chain Length:217
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HEPC46 Heavy Chain
Chain IDs:F, I
Chain Length:230
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.
Cell Host Microbe 24 703 716.e3 (2018)
PMID: 30439340 DOI: 10.1016/j.chom.2018.10.009

Abstact

Hepatitis C virus (HCV) vaccine efforts are hampered by the extensive genetic diversity of HCV envelope glycoproteins E1 and E2. Structures of broadly neutralizing antibodies (bNAbs) (e.g., HEPC3, HEPC74) isolated from individuals who spontaneously cleared HCV infection facilitate immunogen design to elicit antibodies against multiple HCV variants. However, challenges in expressing HCV glycoproteins previously limited bNAb-HCV structures to complexes with truncated E2 cores. Here we describe crystal structures of full-length E2 ectodomain complexes with HEPC3 and HEPC74, revealing lock-and-key antibody-antigen interactions, E2 regions (including a target of immunogen design) that were truncated or disordered in E2 cores, and an antibody CDRH3 disulfide motif that exhibits common interactions with a conserved epitope despite different bNAb-E2 binding orientations. The structures display unusual features relevant to common genetic signatures of HCV bNAbs and demonstrate extraordinary plasticity in antibody-antigen interactions. In addition, E2 variants that bind HEPC3/HEPC74-like germline precursors may represent candidate vaccine immunogens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures